Platelet status in cancer cachexia progression in Apc^Min/+ mice

Area of Science:

• Oncology
• Immunology
• Pathophysiology

Background:

• Cancer cachexia is a complex wasting syndrome impacting cancer patient quality of life.
• High platelet count correlates with decreased survival in cachectic individuals.

Purpose of the Study:

• Investigate the immunopathogenesis of cancer cachexia.
• Identify blood cellular elements, inflammatory markers, and fibrogenic factors in skeletal muscle.
• Characterize the behavioral and metabolic phenotype during cachexia progression.

Main Methods:

• Utilized Apc^Min/+ mouse model for spontaneous colorectal cancer.
• Assessed platelet counts, inflammatory markers (e.g., IL-1β, IL-10), and fibrogenic factors (e.g., TGFβ, SMAD3).
• Conducted behavioral and metabolic phenotyping, including physical activity and anemia assessment.

Main Results:

• Platelet number elevated prior to cachexia development and showed activation during progression.
• Increased TGFβ2, TGFβ3, and SMAD3 in skeletal muscle of pre-cachectic mice.
• Elevated Ly6g, CD206, IL-10 mRNA in severely cachectic mice; elevated IL-1β in pre-cachectic mice.
• Pre-cachectic mice exhibited decreased physical activity and increased anemia.

Conclusions:

• Altered platelet status is evident in early and late stages of cancer cachexia.
• Findings provide a basis for further investigation into the role of platelets in cancer cachexia.
• Identified specific inflammatory markers and behavioral changes associated with cachexia progression.